IS Fentiman

5.4k total citations · 1 hit paper
54 papers, 2.3k citations indexed

About

IS Fentiman is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, IS Fentiman has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cancer Research, 21 papers in Oncology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in IS Fentiman's work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (17 papers) and Cancer Risks and Factors (9 papers). IS Fentiman is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (17 papers) and Cancer Risks and Factors (9 papers). IS Fentiman collaborates with scholars based in United Kingdom, Netherlands and Australia. IS Fentiman's co-authors include DS Allen, M.A. Chaudary, Mitch Dowsett, HV Thomas, TJ Key, T J Key, Desmond Curran, F Mignolet, G.M. Kiebert and Harry Bartelink and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

IS Fentiman

54 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801

1998 272 citations IS Fentiman et al. profile →

Peers

Countries citing papers authored by IS Fentiman

Since Specialization

Citations

This map shows the geographic impact of IS Fentiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by IS Fentiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites IS Fentiman more than expected).

Fields of papers citing papers by IS Fentiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by IS Fentiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by IS Fentiman. The network helps show where IS Fentiman may publish in the future.

Co-authorship network of co-authors of IS Fentiman

This figure shows the co-authorship network connecting the top 25 collaborators of IS Fentiman. A scholar is included among the top collaborators of IS Fentiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with IS Fentiman. IS Fentiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital infrared thermal imaging (DITI) of breast lesions: sensitivity and specificity of detection of primary breast cancers 2011 ·Clinical Radiology ·Michalis Kontos, Rebecca Wilson, IS Fentiman	72
2	γ-Glutamyl transferase and breast cancer risk 2010 ·British Journal of Cancer ·IS Fentiman, D.S. Allen	44
3	A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial 2010 ·British Journal of Cancer ·Sarah E. Pinder, Catherine Duggan, Ian O. Ellis, Jack Cuzick, John Forbes, H Bishop, IS Fentiman, W D George	85
4	17. PSYCHOSOCIAL PROBLEMS FOLLOWING A DIAGNOSIS OF BREAST CANCER 2002 ·International Journal of Clinical Practice ·(unknown), IS Fentiman	13
5	Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS 2001 ·European Journal of Surgical Oncology ·Nina Bijker, Emiel J. Rutgers, J.L. Peterse, IS Fentiman, (unknown), Luc Duchateau, J.A. van Dongen	35
6	Cell proliferation measured by MIB1 and timing of surgery for breast cancer 1998 ·British Journal of Cancer ·(unknown), (unknown), Paul J. Smith, IS Fentiman, DM Barnes	23
7	MALE BREAST CANCER 1998 ·International Journal of Clinical Practice ·(unknown), IS Fentiman	15
8	HORMONE REPLACEMENT THERAPY AND BREAST CANCER 1998 ·International Journal of Clinical Practice ·(unknown), IS Fentiman	1
9	A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey 1997 ·British Journal of Cancer ·HV Thomas, TJ Key, DS Allen, (unknown), Mitch Dowsett, IS Fentiman, (unknown)	238
10	A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey 1997 ·British Journal of Cancer ·HV Thomas, TJ Key, DS Allen, Moore Jw, Mitch Dowsett, IS Fentiman, Dong‐Yu Wang	85
11	Serum progesterone and prognosis in operable breast cancer 1996 ·British Journal of Cancer ·(unknown), Dong‐Yu Wang, WM Gregory, MA Richards, IS Fentiman	34
12	A prospective study of urinary oestrogen excretion and breast cancer risk 1996 ·British Journal of Cancer ·T J Key, (unknown), J. B. Brown, C Hermon, D.S. Allen, (unknown), (unknown), IS Fentiman, MC Pike	47
13	Can mood disorder in women with breast cancer be identified preoperatively? 1995 ·British Journal of Cancer ·AJ Ramirez, (unknown), (unknown), IS Fentiman	60
14	Serum prolactin levels and their relationship to survival in women with operable breast cancer 1995 ·Journal of Clinical Epidemiology ·(unknown), Kasia Stepniewska, D.S. Allen, IS Fentiman, R.D. Bulbrook, H. G. Kwa, Bianca De Stavola, Michael Reed	23
15	A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer 1994 ·British Journal of Cancer ·IS Fentiman, Anthony Howell, (unknown), Siow Ming Lee, Malcolm Ranson, (unknown), (unknown), (unknown), WM Gregory, R A Sellwood	8
16	Mastalgia mostly merits masterly inactivity 1992 ·International Journal of Clinical Practice ·IS Fentiman	4
17	Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer 1991 ·The Lancet ·Rajendra Badwe, W. Gregory, M.A. Chaudary, M A Richards, Anthony Bentley, R.D. Rubens, IS Fentiman	142
18	Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. 1990 ·Journal of Clinical Oncology ·M A Richards, S.M. O'Reilly, Anthony Howell, W D George, IS Fentiman, M.A. Chaudary, D. Crowther, R.D. Rubens	77
19	Cytochrome P450dbl phenotypes in malignant and benign breast disease 1990 ·European Journal of Cancer and Clinical Oncology ·(unknown), H. Hamed, IS Fentiman, Jeffrey R. Idle	10
20	TAMOXIFEN AND BENIGN BREAST PROBLEMS 1987 ·The Lancet ·IS Fentiman, T.J. Powles	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact